After nearly 25 years with Sanofi, Sanjay Gurunathan, M.D., has left for GSK, where he will lead vaccine and infectious ...

UK pharma major GSK has appointed Sanjay Gurunathan as senior vice president and global head vaccines and infectious disease ...

GSK said Wednesday that a Phase 3 trial found ... Sign up here to get The Results Are In with Dr. Sanjay Gupta every Tuesday from the CNN Health team. Data from the trial has not yet been peer ...